Company Filing History:
1 out of 1,748 
1 out of 4,899 
1 out of 5,104 
Years Active: 2012-2025
Title: Eric Denarier: Innovator in Cancer Research and Psychoactive Medicine Screening
Introduction
Eric Denarier is a notable inventor based in Grenoble, France. He has made significant contributions to the fields of cancer research and psychoactive medicine through his innovative inventions. With a total of 2 patents, Denarier's work focuses on developing compounds that enhance the efficacy of anti-cancer agents and create models for screening medicines for psychiatric disorders.
Latest Patents
Denarier's latest patents include groundbreaking inventions. The first patent involves "Carbazole derivatives sensitizing cells to anti-cancer agents." This invention concerns a compound of formula (I), which includes various groups such as hydrogen, halogen, alkyl, acyl, carboxyl, amido, and imino groups. These compounds are designed to improve the effectiveness of anti-cancer treatments.
The second patent is titled "Transgenic or recombinant non-human mammals and their uses in screening psychoactive medicines." This invention focuses on non-human mammals with modified expression of the gene coding for a microtubule-associated protein (MAP). These modified mammals are utilized in screening medicines that are beneficial for treating schizophrenia and schizo-affective disorders, particularly those with anxious, paranoid, or depressive components.
Career Highlights
Throughout his career, Denarier has worked with prestigious organizations. He has been associated with the National Institute of Health and Medical Research (Institut National De La Santé Et De La Recherche Médicale) and the Atomic Energy Commission (Commissariat à l'Énergie Atomique et aux Énergies Alternatives). His work in these institutions has allowed him to contribute to significant advancements in medical research.
Collaborations
Denarier has collaborated with notable colleagues, including Annie Andrieux and Didier Job. These partnerships have further enriched his research and innovation efforts.
Conclusion
Eric Denarier stands out as an influential inventor in the realms of cancer treatment and psychiatric medicine. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.